نتایج جستجو برای: human androgen receptor har

تعداد نتایج: 2028886  

Journal: :Endocrinology 2010
Bin Zhang Qiuqiong Cheng Zhimin Ou Jung Hoon Lee Meishu Xu Upasana Kochhar Songrong Ren Min Huang Beth R Pflug Wen Xie

The androgen-androgen receptor signaling pathway plays an important role in the pathogenesis of prostate cancer. Accordingly, androgen deprivation has been the most effective endocrine therapy for hormone-dependent prostate cancer. Here, we report a novel pregnane X receptor (PXR)-mediated and metabolism-based mechanism to reduce androgenic tone. PXR is a nuclear receptor previously known as a ...

Journal: :The British journal of ophthalmology 2000
E M Rocha L A Wickham L A da Silveira K L Krenzer F S Yu I Toda B D Sullivan D A Sullivan

BACKGROUND/AIMS Androgens have been reported to influence the structural organisation, functional activity, and/or pathological features of many ocular tissues. In addition, these hormones have been proposed as a topical therapy for such conditions as dry eye syndromes, corneal wound healing, and high intraocular pressure. To advance our understanding of androgen action in the eye, the purpose ...

Journal: :The Journal of surgical research 2011
Roman Telpner Ron Ben-Abraham Yifat Klein Richard Nakache Wisam Khoury Avi A Weinbroum

BACKGROUND Discordant xenotransplantation, the grafting of organs from one phylogenic species to another, results in hyper-acute rejection (HAR). HAR is associated with the deposition of recipient preformed xenoreactive natural antibodies and complement on the endothelium of the donor organ, leading to activation and apoptosis of the endothelium, an event associated with xenograft rejection. En...

2006
W. D. Tilley C. M. Wilson M. Marcelli M. J. McPhaul

Responses to androgen vary widely among prostate cancers and prostatic carcinoma cell lines. We have explored the basis for this heteroge neity by examining the levels of androgen receptor expression in a prostate carcinoma cell line (LNCaP) that expresses the androgen recep tor and two prostate carcinoma cell lines that do not contain detectable androgen receptor. We find that while the LNCaP ...

Journal: :Cancer research 2006
Chih-pin Chuu Richard A Hiipakka John M Kokontis Junichi Fukuchi Rou-Yu Chen Shutsung Liao

Androgen-dependent human LNCaP 104-S tumor xenografts progressed to androgen-independent relapsed tumors (104-Rrel) in athymic mice after castration. The growth of 104-Rrel tumors was suppressed by testosterone. However, 104-Rrel tumors adapted to androgen and regrew as androgen-stimulated 104-Radp tumors. Androgen receptor expression in tumors and serum prostate-specific antigen increased duri...

Journal: :Cancer research 1998
C W Gregory K G Hamil D Kim S H Hall T G Pretlow J L Mohler F S French

The human prostate cancer (CaP) xenograft, CWR22, mimics human CaP. CWR22 grows in testosterone-stimulated nude mice, regresses after castration, and recurs after 5-6 months in the absence of testicular androgen. Like human CaP that recurs during androgen deprivation therapy, the recurrent CWR22 expresses high levels of androgen receptor (AR). Immunohistochemical, Western, and Northern blot ana...

Journal: :Annals of the New York Academy of Sciences 1993
L J Blok P E de Ruiter A O Brinkmann

Phosphorylation of transcription factors plays an important role in regulation of gene expression. DNA-binding, transactivation activity, and subcellular trafficking of specific transcription factors have been shown to be regulated by phosphorylation/dephosphorylation. Steroid hormone receptors are phospho-proteins, and mutations in phosphorylation sites significantly affect the transactivation...

2016
Greg L. Shaw Hayley Whitaker Marie Corcoran Mark J. Dunning Hayley Luxton Jonathan Kay Charlie E. Massie Jodi L. Miller Alastair D. Lamb Helen Ross-Adams Roslin Russell Adam W. Nelson Matthew D. Eldridge Andrew G. Lynch Antonio Ramos-Montoya Ian G. Mills Angela E. Taylor Wiebke Arlt Nimish Shah Anne Y. Warren David E. Neal

UNLABELLED The androgen receptor (AR) is the dominant growth factor in prostate cancer (PCa). Therefore, understanding how ARs regulate the human transcriptome is of paramount importance. The early effects of castration on human PCa have not previously been studied 27 patients medically castrated with degarelix 7 d before radical prostatectomy. We used mass spectrometry, immunohistochemistry, a...

2006
W. D. Tilley C. M. Wilson M. Marcelli M. J. McPhaul

Responses to androgen vary widely among prostate cancers and prostatic carcinoma cell lines. We have explored the basis for this heteroge neity by examining the levels of androgen receptor expression in a prostate carcinoma cell line (LNCaP) that expresses the androgen recep tor and two prostate carcinoma cell lines that do not contain detectable androgen receptor. We find that while the LNCaP ...

Journal: :Cancer research 2002
Isaac Yi Kim Do Hwan Seong Byung-Chul Kim Dug Keun Lee Alan T Remaley Fredrick Leach Ronald A Morton Seong-Jin Kim

Raloxifene, a selective estrogen receptor (ER) modulator, is a mixed estrogen agonist/antagonist that has been shown to prevent osteoporosis and breast cancer in women. Because the prostate contains a high level of ER-beta, the present study investigated the effect of raloxifene in the androgen-sensitive human prostate cancer cell line LNCaP. Previously, it has been demonstrated that LNCaP cell...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید